Upgrade to SI Premium - Free Trial

BofA Securities Reiterates Buy Rating on BioNTech (BNTX)

November 4, 2024 12:47 PM
BofA Securities analyst Tazeen Ahmad reiterated a Buy rating and $150.00 price target on BioNTech (NASDAQ: BNTX).The analyst comments "BioNTech ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles